Literature DB >> 9228228

Effect of ebastine on mosquito bites.

T Reunala1, H Brummer-Korvenkontio, L Petman, T Palosuo, S Sarna.   

Abstract

Mosquito bites usually cause wealing and delayed bite papules. Cetirizine decreases wealing, bite papules and pruritus but the effect of other antihistamines on mosquito bites is unknown. We studied the effect of ebastine in 30 mosquito bite-sensitive adult subjects. Ebastine 10 mg or 20 mg and placebo were given for 4 days in a cross-over fashion. Aedes aegypti bites were given on forearms. The size of the bite lesions and pruritus (visual analogue score) were measured at 15 min, 2, 6, and 24 h after the bites. Twenty-five subjects were evaluable in the study. At 15 min ebastine decreased significantly the size of the bite lesion (p = 0.0017) and pruritus (p<0.0001). The effects of 10 mg and 20 mg of ebastine were similar. No significant effect was found at 2, 6 or 24 h, but when the measurements at all four time points were compiled the size of the bite lesion and pruritus score decreased significantly. Sedation occurred during ebastine treatment in 6 (21%) and during placebo treatment in 2 (7%) subjects. The present results show that prophylactically given ebastine is effective against immediate mosquito bite symptoms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228228     DOI: 10.2340/0001555577315316

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

Review 1.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Oral antihistamines for insect bites.

Authors:  Bernard A Foëx; Caroline Lee
Journal:  Emerg Med J       Date:  2006-09       Impact factor: 2.740

3.  A clinical study to optimise a sand fly biting protocol for use in a controlled human infection model of cutaneous leishmaniasis (the FLYBITE study).

Authors:  Vivak Parkash; Helen Ashwin; Jovana Sadlova; Barbora Vojtkova; Georgina Jones; Nina Martin; Elizabeth Greensted; Victoria Allgar; Shaden Kamhawi; Jesus G Valenzuela; Alison M Layton; Charles L Jaffe; Petr Volf; Paul M Kaye; Charles J N Lacey
Journal:  Wellcome Open Res       Date:  2021-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.